Apr. 21 at 6:25 PM
$SKYE right now we have a market cap
$26 million. If this drug shows any kind of difference another company’s gonna pick it up the technologies is worth more than 26 million. The research is worth more than 26 million somebody’s gonna come over and offer this company a dollar too if people are gonna be pissed just watch no biotech technology is absolutely worthless unless it has complete complete failure and his company has shown some significant improvements. It needs to be tweaked and when it gets tweaked, it’s gonna be a multiple of five times or 10 times where it is now so bears can short it all they want. I believe there’s more value here than
$50 million in the endgame and that means at least a double from here.
